Su Ling Loo

Dr. Su Ling Loo is a Postdoctoral Researcher at the University of Newcastle's School of Biomedical Sciences and Pharmacy, specializing in viral immunology and respiratory diseases. She completed her PhD in 2018, during which she developed a coronavirus infection model using air-liquid interface cultures. Her work focuses on respiratory viruses like coronaviruses and rhinoviruses, with applications in testing antiviral products and screening immune stimulant compounds.

Education:

• Doctor of Philosophy (2018), University of Newcastle
• Bachelor of Science (201X), University of Newcastle
• Bachelor of Biomedical Sciences (Honours) (201X), University of Newcastle

Research Interests: Dr. Loo investigates viral infections in airway epithelial cells, antiviral immunity mechanisms, and translational research to combat respiratory diseases. Her work bridges basic science and industry collaborations, such as projects with Ena Therapeutics targeting innate immune modulation.

Awards:

• Best Presentation in Cell, Immunology & Molecular Biology of the Lung SIG (2018)
• Translational Basic Science Award (2017)
• Lung Foundation Australia David Serisier Memorial Award (2017)

Grants & Supervision: Dr. Loo co-leads grants totaling $100,261, including studies on immune modulators for respiratory viruses. She currently co-supervises a PhD student researching ocular pain drug delivery.

Labs & Networks: Affiliated with the Priority Research Centre for Healthy Lungs, contributing to UN Sustainable Development Goals. Her work is widely cited in journals like Nature Communications and has influenced clinical guidelines and industry practices.